X-linked nonsyndromic hearing loss

MONDO:0019586

X-linked form of nonsyndromic deafness.

Also known as: X-linked isolated neurosensory hearing loss type DFN, X-linked isolated sensorineural hearing loss type DFN, X-linked non-syndromic neurosensory hearing loss type DFN, X-linked non-syndromic sensorineural hearing loss type DFN, X-linked deafness, X-linked isolated neurosensory deafness type DFN, X-linked isolated sensorineural deafness type DFN, X-linked non-syndromic neurosensory deafness type DFN

32 clinical trials for this condition and its sub-types, 0 tagged with X-linked nonsyndromic hearing loss itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Nonsyndromic genetic hearing loss (67) ↑ X-linked deafness (32)

Sub-types of X-linked nonsyndromic hearing loss

X-linked mixed hearing loss with perilymphatic gusher 32 trials
X-linked hereditary sensory and autonomic neuropathy with hearing loss 0 trials
Hearing loss, X-linked 1 0 trials
Hearing loss, X-linked 3 0 trials
Hearing loss, X-linked 4 0 trials
Hearing loss, X-linked 6 0 trials

Including sub-types (32) Tagged with X-linked nonsyndromic hearing loss (0)

Trials to join now! 11 Not yet recruiting 6 Not yet finished but already full! 4 Completed 10 Terminated 1

Can an antiviral drug protect hearing in infants with congenital CMV?

Disease control Stopped early

This trial tests whether the antiviral drug valganciclovir can improve hearing and language outcomes in infants who have hearing loss due to congenital cytomegalovirus (CMV) infection. Infants aged 1 to 12 months with confirmed sensorineural hearing loss will receive either valga…

Phase 2 • Sponsor: Albert Park • Aim: Disease control

Last updated Aug 29, 2026 00:00 UTC

X-linked nonsyndromic hearing loss

Where it sits in the disease tree

Can an antiviral drug protect hearing in infants with congenital CMV?